David Daly
2016 - Foundation Medicine
In 2016, David Daly earned a total compensation of $1.9M as Chief Commercial Officer and General Manager, Clinical Oncology Solutions at Foundation Medicine, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $122,875 |
|---|---|
| Salary | $365,427 |
| Stock Awards | $1,277,500 |
| Other | $112,936 |
| Total | $1,878,738 |
Daly received $1.3M in stock awards, accounting for 68% of the total pay in 2016.
Daly also received $122.9K in non-equity incentive plan, $365.4K in salary and $112.9K in other compensation.
Rankings
In 2016, David Daly's compensation ranked 5,173rd out of 14,075 executives tracked by ExecPay. In other words, Daly earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,173 out of 14,075 | 63rd |
Division Services | 908 out of 2,282 | 60th |
Major group Health Services | 78 out of 209 | 63rd |
Industry group Medical And Dental Laboratories | 16 out of 61 | 74th |
Industry Medical Laboratories | 16 out of 61 | 74th |
Source: SEC filing on April 28, 2017.
Daly's colleagues
We found two more compensation records of executives who worked with David Daly at Foundation Medicine in 2016.